BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ankrah AO, Glaudemans AWJM, Maes A, Van de Wiele C, Dierckx RAJO, Vorster M, Sathekge MM. Tuberculosis. Semin Nucl Med 2018;48:108-30. [PMID: 29452616 DOI: 10.1053/j.semnuclmed.2017.10.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Sarda-Mantel L, Kaoutar J, Alfaiate T, Lopes A, Paycha F, Benali K, Mikail N, Soussan M, Lemarignier C, Méchaï F, Nagat SL, Montravers F, Deradji O, Durand E, Goulenok T, Ponscarme D, Yéni P, Laouénan C, Rioux C. [ 18 F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis. Front Med (Lausanne) 2021;8:715115. [PMID: 34485345 DOI: 10.3389/fmed.2021.715115] [Reference Citation Analysis]
2 Chen L, Liu C, Ye Z, Huang S, Liang T, Li H, Chen J, Chen W, Guo H, Chen T, Yao Y, Jiang J, Sun X, Yi M, Liao S, Yu C, Wu S, Fan B, Zhan X. Predicting Surgical Site Infection Risk after Spinal Tuberculosis Surgery: Development and Validation of a Nomogram. Surg Infect (Larchmt) 2022. [PMID: 35723640 DOI: 10.1089/sur.2022.042] [Reference Citation Analysis]
3 Sood A, Mittal BR, Modi M, Chhabra R, Verma R, Rana N, Parihar AS, Satapathy S, Kumar R. 18F-FDG PET/CT in Tuberculosis: Can Interim PET/CT Predict the Clinical Outcome of the Patients? Clin Nucl Med 2020;45:276-82. [PMID: 32108701 DOI: 10.1097/RLU.0000000000002968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Shaw JA, Diacon AH, Koegelenberg CFN. Tuberculous pleural effusion. Respirology 2019;24:962-71. [PMID: 31418985 DOI: 10.1111/resp.13673] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
5 Yu WY, Zhang QQ, Xiao Y, Tan WG, Li XD, Lu PX. Correlation between 18F-FDG PET CT SUV and symptomatic or asymptomatic pulmonary tuberculosis. J Xray Sci Technol 2019;27:899-906. [PMID: 31282469 DOI: 10.3233/XST-190543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lawal IO, Fourie BP, Mathebula M, Moagi I, Lengana T, Moeketsi N, Nchabeleng M, Hatherill M, Sathekge MM. 18F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis. J Nucl Med 2020;61:412-7. [PMID: 31451489 DOI: 10.2967/jnumed.119.233783] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
7 Hunter RL. The Pathogenesis of Tuberculosis: The Early Infiltrate of Post-primary (Adult Pulmonary) Tuberculosis: A Distinct Disease Entity. Front Immunol 2018;9:2108. [PMID: 30283448 DOI: 10.3389/fimmu.2018.02108] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
8 More S, Marakalala MJ, Sathekge M. Tuberculosis: Role of Nuclear Medicine and Molecular Imaging With Potential Impact of Neutrophil-Specific Tracers. Front Med 2021;8:758636. [DOI: 10.3389/fmed.2021.758636] [Reference Citation Analysis]
9 Solcia MC, Campos DL, Grecco JA, Paiva Silva CS, Bento da Silva P, Cristiane da Silva I, Balduino da Silva AP, Silva J, Oda FB, Gonzaga Dos Santos A, Pavan FR. Growth-inhibitory effects of tris-(1,10-phenanthroline) iron (II) against Mycobacterium tuberculosis in vitro and in vivo. Tuberculosis (Edinb) 2021;128:102087. [PMID: 34022507 DOI: 10.1016/j.tube.2021.102087] [Reference Citation Analysis]
10 Bresser PL, Vorster M, Sathekge MM. An overview of the developments and potential applications of 68Ga-labelled PET/CT hypoxia imaging. Ann Nucl Med 2021;35:148-58. [PMID: 33400147 DOI: 10.1007/s12149-020-01563-7] [Reference Citation Analysis]
11 Al-zaghal A, Raynor WY, Seraj SM, Werner TJ, Alavi A. FDG-PET imaging to detect and characterize underlying causes of fever of unknown origin: an unavoidable path for the foreseeable future. Eur J Nucl Med Mol Imaging 2019;46:2-7. [DOI: 10.1007/s00259-018-4164-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Li Z, Wu D, Zhan B, Hu X, Gan J, Ji C, Li J. Structural insights into the complex of trigger factor chaperone and ribosomal protein S7 from Mycobacterium tuberculosis. Biochem Biophys Res Commun 2019;512:838-44. [PMID: 30928093 DOI: 10.1016/j.bbrc.2019.03.166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Wei M, Yongjie Zhao, Zhuoyu Qian, Biao Yang, Xi J, Wei J, Tang B. Pneumonia caused by Mycobacterium tuberculosis. Microbes Infect 2020;22:278-84. [PMID: 32561408 DOI: 10.1016/j.micinf.2020.05.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Li X, Zhou Y, Du P, Lang G, Xu M, Wu W. A deep learning system that generates quantitative CT reports for diagnosing pulmonary Tuberculosis. Appl Intell 2021;51:4082-93. [DOI: 10.1007/s10489-020-02051-1] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
15 Ji Y, Shao C, Cui Y, Shao G, Zheng J. 18F-FDG Positron-Emission Tomography/Computed Tomography Findings of Radiographic Lesions Suggesting Old Healed Pulmonary Tuberculosis and High-risk Signs of Predicting Recurrence: A Retrospective Study. Sci Rep 2019;9:12582. [PMID: 31467384 DOI: 10.1038/s41598-019-49057-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Burger C, Holness JL, Smit DP, Griffith-Richards S, Koegelenberg CFN, Ellmann A. The Role of 18F-FDG PET/CT in Suspected Intraocular Sarcoidosis and Tuberculosis. Ocul Immunol Inflamm 2021;29:530-6. [PMID: 31743044 DOI: 10.1080/09273948.2019.1685109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Yanarateş A, Budak E. Disseminated Tuberculosis and Saccular Aneurysm Findings on FDG PET/CT in a Patient With Polyarteritis Nodosa. J Clin Rheumatol 2021;27:e67-8. [PMID: 31764382 DOI: 10.1097/RHU.0000000000001239] [Reference Citation Analysis]
18 Yu WY, Lu PX, Assadi M, Huang XL, Skrahin A, Rosenthal A, Gabrielian A, Tartakovsky M, Wáng YXJ. Updates on 18F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring. Quant Imaging Med Surg 2019;9:1132-46. [PMID: 31367568 DOI: 10.21037/qims.2019.05.24] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
19 Hunter RL. The Pathogenesis of Tuberculosis-The Koch Phenomenon Reinstated. Pathogens 2020;9:E813. [PMID: 33020397 DOI: 10.3390/pathogens9100813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 Palestro CJ. Letter from the Guest Editor. Semin Nucl Med 2018;48:84-5. [PMID: 29452622 DOI: 10.1053/j.semnuclmed.2017.11.005] [Reference Citation Analysis]
21 Deogaonkar V, Chandra Khangembam B, Seraj SM, Alavi A, Kumar R, Vangu MD, Bisson G. Novel Quantitative PET Imaging Techniques in Tuberculosis. PET Clin 2020;15:231-40. [PMID: 32145893 DOI: 10.1016/j.cpet.2019.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Xu M, Liao J, Yin P, Hou J, Zhou Y, Huang J, Liu B, Chen R, Ke L, Chen H, Hu P. Association of air pollution with the risk of initial outpatient visits for tuberculosis in Wuhan, China. Occup Environ Med 2019;76:560-6. [DOI: 10.1136/oemed-2018-105532] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
23 Chen Q, Chen W, Hao F. Cutaneous tuberculosis: A great imitator. Clin Dermatol 2019;37:192-9. [PMID: 31178102 DOI: 10.1016/j.clindermatol.2019.01.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
24 Bresser PL, Sathekge MM, Vorster M. PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept study. Nucl Med Commun 2022. [PMID: 35506285 DOI: 10.1097/MNM.0000000000001580] [Reference Citation Analysis]
25 Goletti D, Lindestam Arlehamn CS, Scriba TJ, Anthony R, Cirillo DM, Alonzi T, Denkinger CM, Cobelens F. Can we predict tuberculosis cure? What tools are available? Eur Respir J 2018;52:1801089. [PMID: 30361242 DOI: 10.1183/13993003.01089-2018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
26 Rahim MA, Seo H, Kim S, Tajdozian H, Barman I, Lee Y, Lee S, Song HY. In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota. Sci Rep 2022;12:8290. [PMID: 35585245 DOI: 10.1038/s41598-022-12413-z] [Reference Citation Analysis]
27 Lin PL, Flynn JL. The End of the Binary Era: Revisiting the Spectrum of Tuberculosis. J Immunol 2018;201:2541-8. [PMID: 30348659 DOI: 10.4049/jimmunol.1800993] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 13.7] [Reference Citation Analysis]
28 Palestro CJ. Molecular Imaging of Infection: The First 50 Years. Semin Nucl Med 2020;50:23-34. [PMID: 31843059 DOI: 10.1053/j.semnuclmed.2019.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Bhattacharya B, Ranjan P, Prakash S, Damle NA, Chakraborty S, Sikdar S. Antibiotic scintigraphy in tuberculosis: A new horizon? Indian Journal of Tuberculosis 2022;69:20-6. [DOI: 10.1016/j.ijtb.2021.03.012] [Reference Citation Analysis]
30 Lawal IO, Mokoala KMG, Mathebula M, Moagi I, Popoola GO, Moeketsi N, Nchabeleng M, Hikuam C, Ellner JJ, Hatherill M, Fourie BP, Sathekge MM. Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis. Front Med (Lausanne) 2022;9:791653. [PMID: 35295606 DOI: 10.3389/fmed.2022.791653] [Reference Citation Analysis]
31 Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A, Erba AP, Ferrari C, Mainolfi CG, Palucci A, Prandini N, Baldari S, Bartoli F, Bartolomei M, D'Antonio A, Dondi F, Gandolfo P, Giordano A, Laudicella R, Massollo M, Nieri A, Piccardo A, Vendramin L, Muratore F, Lavelli V, Albano D, Burroni L, Cuocolo A, Evangelista L, Lazzeri E, Quartuccio N, Rossi B, Rubini G, Sollini M, Versari A, Signore A. State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging 2021;9:299-339. [PMID: 34277510 DOI: 10.1007/s40336-021-00445-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
32 Symes MJ, Probyn B, Daneshvar C, Telisinghe L. Diagnosing Pulmonary Tuberculosis in the Elderly. Curr Geri Rep 2020;9:30-9. [DOI: 10.1007/s13670-020-00319-5] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Pijl JP, Nienhuis PH, Kwee TC, Glaudemans AWJM, Slart RHJA, Gormsen LC. Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation. Semin Nucl Med 2021:S0001-2998(21)00040-4. [PMID: 34246448 DOI: 10.1053/j.semnuclmed.2021.06.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]